Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
28.00
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Price to Book Value : 7.292 for March 6, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 06, 2024 | 7.292 |
| March 05, 2024 | 7.289 |
| March 04, 2024 | 7.287 |
| March 01, 2024 | 7.289 |
| February 29, 2024 | 7.279 |
| February 28, 2024 | 7.279 |
| February 27, 2024 | 7.271 |
| February 26, 2024 | 7.279 |
| February 23, 2024 | 7.279 |
| February 22, 2024 | 7.276 |
| February 21, 2024 | 7.216 |
| February 20, 2024 | 7.227 |
| February 16, 2024 | 7.235 |
| February 15, 2024 | 7.229 |
| February 14, 2024 | 7.235 |
| February 13, 2024 | 7.235 |
| February 12, 2024 | 7.240 |
| February 09, 2024 | 7.240 |
| February 08, 2024 | 7.240 |
| February 07, 2024 | 7.240 |
| February 06, 2024 | 7.237 |
| February 05, 2024 | 7.237 |
| February 02, 2024 | 7.240 |
| February 01, 2024 | 7.237 |
| January 31, 2024 | 7.242 |
| Date | Value |
|---|---|
| January 30, 2024 | 7.240 |
| January 29, 2024 | 7.240 |
| January 26, 2024 | 7.232 |
| January 25, 2024 | 7.235 |
| January 24, 2024 | 7.203 |
| January 23, 2024 | 7.227 |
| January 22, 2024 | 7.242 |
| January 19, 2024 | 7.203 |
| January 18, 2024 | 7.188 |
| January 17, 2024 | 7.188 |
| January 16, 2024 | 7.211 |
| January 12, 2024 | 7.287 |
| January 11, 2024 | 7.318 |
| January 10, 2024 | 7.268 |
| January 09, 2024 | 7.177 |
| January 08, 2024 | 7.156 |
| January 05, 2024 | 3.551 |
| January 04, 2024 | 3.480 |
| January 03, 2024 | 3.540 |
| January 02, 2024 | 3.527 |
| December 29, 2023 | 3.710 |
| December 28, 2023 | 3.778 |
| December 27, 2023 | 3.830 |
| December 26, 2023 | 3.788 |
| December 22, 2023 | 3.720 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.070 |
| Axonics Inc (DELISTED) | -- |
| Harpoon Therapeutics Inc (DELISTED) | 108.42 |
| Merck & Co., Inc. | 6.411 |
| RayzeBio inc (DELISTED) | 6.508 |
Price to Book Value Related Metrics
| PS Ratio | 1776.23 |
| Earnings Yield | -1.82% |